Holen Sie sich die Stockscreener-App
17.04
2.04%
0.34
Handel nachbörslich:
17.04
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Is Eton Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Retail & Low Risk High Reward Trade Ideas - sundaytimes.kr
What makes Eton Pharmaceuticals Inc. stock price move sharply2025 Earnings Impact & Risk Controlled Daily Trade Plans - Newser
Visualizing Eton Pharmaceuticals Inc. stock with heatmapsWeekly Stock Summary & Weekly Market Pulse Alerts - Newser
What data driven models say about Eton Pharmaceuticals Inc.’s futureWeekly Risk Summary & Long-Term Capital Growth Ideas - Newser
Is Eton Pharmaceuticals Inc. trending in predictive chart models2025 Biggest Moves & Safe Swing Trade Setups - Newser
Identifying reversal signals in Eton Pharmaceuticals Inc.2025 Valuation Update & High Accuracy Trade Alerts - Newser
How high can Eton Pharmaceuticals Inc. stock goJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - Newser
Chart overlay techniques for tracking Eton Pharmaceuticals Inc.Quarterly Portfolio Review & Reliable Intraday Trade Plans - Newser
XTX Topco Ltd Sells 2,858 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Why Eton Pharmaceuticals Inc. is moving todayMarket Movement Recap & Community Supported Trade Ideas - Newser
Eton Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesEarnings Miss & Community Driven Trade Alerts - Newser
Published on: 2025-08-13 17:16:40 - sundaytimes.kr
How to interpret RSI for Eton Pharmaceuticals Inc. stock [Gap Up]Free Low Drawdown Trading Techniques - Newser
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript - Insider Monkey
With 43% Ownership in Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
Loss-Making Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Set To Breakeven - simplywall.st
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates - MSN
Eton Pharmaceuticals Experiences Record Revenue Growth and Analysts See Significant Upside Potential - AInvest
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveFree Stock Selection With High Accuracy - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.Free Secure Capital Picks With Upside Potential - Newser
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
What institutional flow reveals about Eton Pharmaceuticals Inc.Swing Candidate List with Trade Cues - Newser
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth - Investing.com
Eton Pharmaceuticals Soars 17.23% on 108% Sales Growth - AInvest
Analyzing Eton Pharmaceuticals: A Reasonable Growth Opportunity with Affordable Pricing and Potential Upside from Options. - AInvest
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals Reports Robust Q2 2025 Growth - TipRanks
Real time pattern detection on Eton Pharmaceuticals Inc. stockBuy/Sell Zone Confirmation Technical Analysis - Newser
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c - TipRanks
Eton Pharmaceuticals earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Eton Pharmaceuticals Earnings: 108% Revenue Jump and Early Milestone Achievement Signals Breakout Growth - Stock Titan
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersLow Risk High Confidence Watchlist Builder - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
Quant Tools Rank Eton Pharmaceuticals Inc. as High Risk High RewardVerified Signal From Chart Patterns Detected - beatles.ru
How does Eton Pharmaceuticals Inc. compare to its industry peersMarket-leading profit generation - Jammu Links News
How many analysts rate Eton Pharmaceuticals Inc. as a “Buy”Get daily expert analysis for smarter investing - Jammu Links News
What is the risk reward ratio of investing in Eton Pharmaceuticals Inc. stockFree Stock Market Trend Analysis - Jammu Links News
How volatile is Eton Pharmaceuticals Inc. stock compared to the marketBoost your wealth with consistent growth stocks - Jammu Links News
Is Eton Pharmaceuticals Inc. a good long term investmentFree Stock Market Query - Jammu Links News
Is Eton Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Why is Eton Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve consistent profits with smart trading - Jammu Links News
What catalysts could drive Eton Pharmaceuticals Inc. stock higher in 2025Track stocks with high upside potential easily - Jammu Links News
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):